Why it matters:
The funds in question were originally allocated for vaccine purchases through the COVAX initiative but remain inaccessible due to banking restrictions and sanctions.
The big picture:
Iran’s COVAX Payment Dispute with WHO:
- Fall 2020: Iran attempted to pre-purchase COVID-19 vaccines through the COVAX initiative but faced obstacles transferring funds due to international sanctions.
- December 2020: Iranian monetary authorities announced a payment of approximately $244 million for 16.8 million doses of vaccine.
- Spring–Summer 2021: Iran confirmed it had paid its full COVAX share. Part of the currency transfer,$125 million, was authorized from Iran’s frozen assets in Iraq.
- 2021–2022: Vaccine deliveries began via COVAX, but like many countries, Iran experienced delays and shortfalls due to global supply issues. This led to unresolved balances and disputes over final settlements, which remain under discussion.
What he’s saying:
Iranian Health Minister: “The remaining funds must be quickly released and redirected to serve the health needs of the Iranian people.”
“Health must not fall victim to politics.”
“Regional cooperation in medicine and equipment production is essential for long-term independence.”
Context:
Zafarghandi made the remarks during a meeting with Dr. Hanan Balkhy, WHO Regional Director for the Eastern Mediterranean, on the sidelines of the 72nd WHO Regional Committee meeting in Cairo.
Go deeper:
Iran's Health Minister: Global Health Team Should Stay Away From Politicking
Neda Sajjadi - seyed mohammad kazemi
